Galip Can Uyar, Medical Doctor at Etlik City Hospital, shared a post on X:
“Serum GDF-15 levels are markedly elevated in pancreatic cancer patients compared to healthy controls.
Mean GDF-15:
– 598 pg/mL in controls vs. 2,505 pg/mL in PC patients
– Higher in unresectable cachectic PC (3,029 pg/mL) vs. resectable disease (2,088 pg/mL, P = .0227)
Trend toward higher GDF-15 with neoadjuvant therapy and chemotherapy initiation.
Reinforces GDF-15 as a therapeutic target for cancer cachexia.”
Title: Growth Differentiation Factor 15 Serum Levels in Pancreatic Cancer
Authors: Abrahm Levi, Jun Gong, Veronica R. Placencio, Talya Geller, Matthew Ebia, Hsiao D. Lieu, Andrew Eugene Hendifar
Read The Full Article ASCO Publications.
More posts featuring Galip Can Uyar on OncoDaily.